Finance entity
ipo is the sole category represented across all 1 tracked stories. Gaudium IVF and Women Health is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.2.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
ipo is the sole category represented across all 1 tracked stories. Gaudium IVF and Women Health is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.2. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Gaudium IVF appears in 1 tracked Finance story from February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 85 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gaudium IVF. Shared-story counts are live from our verified record — not editorial picks.
Tentative Listing
Expected date for the shares to begin trading on the NSE and BSE.
Allotment Finalization
The basis of allotment is expected to be finalized for investors.
Final Bidding Day
The window for all investor categories to place bids closes.
Day 2 Close
Subscription reaches 3x with strong retail participation.
IPO Opens
Gaudium IVF opens its initial public offering for subscription.
Gaudium IVF and Women Health's initial public offering has entered its final day of bidding with a 3.00x subscription rate and a 6.33% grey market premium. The issue has seen particularly strong interest from retail and non-institutional investors as the company seeks to expand its footprint in India's growing fertility market.
Gaudium IVF is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
